Related Experiment Video
Updated: Feb 15, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Macrophage Migration Inhibitory Factor and microRNA-451a in Response to Mindfulness-based Therapy or Treatment as
Xiao Wang1, Kristina Sundquist1, Karolina Palmér1
1Center for Primary Health Care Research, Lund University/Region Skåne, Sweden.
Background:
Macrophage migration inhibitory factor is a proinflammatory cytokine that has been associated with various psychiatric disorders. MicroRNA-451a can directly target macrophage migration inhibitory factor and downregulate its expression in cells. However, the role of macrophage migration inhibitory factor and microRNA-451a in psychiatric patients treated with psychotherapeutic interventions is unknown. In this study, our aim was to investigate levels of macrophage migration inhibitory factor and its regulating microRNA-451a in patients with depression, anxiety, or stress and adjustment disorders who underwent mindfulness-based therapy or treatment as usual.
Methods:
A total of 168 patients with psychiatric disorders were included from a randomized controlled trial that compared mindfulness-based therapy with treatment as usual. Plasma levels of macrophage migration inhibitory factor and microRNA-451a were measured at baseline and after the 8-week follow-up using Luminex assay and qPCR.
Results:
Macrophage migration inhibitory factor levels decreased significantly in patients posttreatment, whereas microRNA-451a levels showed a nonsignificant change. Macrophage migration inhibitory factor levels were inversely associated with microRNA-451a expression levels at baseline (β=-0.04, P=.008). The change in macrophage migration inhibitory factor levels (follow-up levels minus baseline levels) was associated with the change in microRNA-451a (follow-up levels minus baseline levels) (β=-0.06, P < .0001). The change in either macrophage migration inhibitory factor or microRNA-451a was not associated with improvement in psychiatric symptoms.
Conclusion:
We demonstrate that the levels of macrophage migration inhibitory factor decreased after psychotherapeutic interventions in patients with psychiatric disorders. However, this reduction was not associated with an improvement in psychiatric symptoms in response to the treatment. We also found an association between macrophage migration inhibitory factor and its regulating microRNA. However, this association needs to be further examined in future studies.
Insights
Psychiatric patients showed decreased macrophage migration inhibitory factor (MIF) after therapy, but this did not correlate with symptom improvement. MIF and microRNA-451a levels were associated, warranting further investigation.
Area of Science:
- Neuroscience
- Molecular Biology
- Psychiatry
Background:
- Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine linked to psychiatric disorders.
- MicroRNA-451a (miR-451a) regulates MIF expression.
- The roles of MIF and miR-451a in psychiatric patients undergoing therapy are largely unknown.
Purpose of the Study:
- To investigate the levels of MIF and miR-451a in patients with depression, anxiety, or stress and adjustment disorders.
- To examine the relationship between MIF, miR-451a, and psychotherapeutic interventions.
Main Methods:
- 168 patients from a randomized controlled trial comparing mindfulness-based therapy and treatment as usual were analyzed.
- Plasma MIF and miR-451a levels were measured at baseline and after 8 weeks using Luminex assay and qPCR.
Main Results:
- MIF levels significantly decreased posttreatment, while miR-451a levels showed no significant change.
- MIF levels were inversely associated with miR-451a at baseline and showed a significant association in change over time.
- Neither MIF nor miR-451a changes correlated with improvements in psychiatric symptoms.
Conclusions:
- Psychotherapeutic interventions led to decreased MIF levels in psychiatric patients, independent of symptom improvement.
- A significant association between MIF and miR-451a was observed, suggesting a regulatory relationship.
- Further research is needed to elucidate the complex interplay between MIF, miR-451a, and psychiatric disorders.
More Related Videos
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
12:22Mindfulness in Motion MIM: An Onsite Mindfulness Based Intervention MBI for Chronically High Stress Work Environments to Increase Resiliency and Work Engagement
Published on: July 1, 2015
Related Concept Videos
Social Anxiety Disorder
Generalized Anxiety Disorder
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Responses to Heat and Cold Stress
Responses to Salt Stress
Depressive Disorders: MDD and Dysthymia